Gold nanoparticles in nanobiotechnology: from synthesis to biosensing applications

A Karnwal, RS Kumar Sachan, I Devgon, J Devgon… - ACS …, 2024 - ACS Publications
Nanobiotechnology has ushered in a new era of scientific discovery where the unique
properties of nanomaterials, such as gold nanoparticles, have been harnessed for a wide …

Aptamer-based lateral flow assay on-site biosensors

L Huang, S Tian, W Zhao, K Liu, X Ma, J Guo - Biosensors and …, 2021 - Elsevier
The lateral flow assay (LFA) is a widely used paper-based on-site biosensor that can detect
target analytes and obtain test results in several minutes. Generally, antibodies are utilized …

[HTML][HTML] Development of nucleic acid aptamer-based lateral flow assays: A robust platform for cost-effective point-of-care diagnosis

T Wang, L Chen, A Chikkanna, S Chen, I Brusius… - Theranostics, 2021 - ncbi.nlm.nih.gov
Lateral flow assay (LFA) has made a paradigm shift in the in vitro diagnosis field due to its
rapid turnaround time, ease of operation and exceptional affordability. Currently used LFAs …

Aptamer-Based lateral flow assays: Current trends in clinical diagnostic rapid tests

M Majdinasab, M Badea, JL Marty - Pharmaceuticals, 2022 - mdpi.com
The lateral flow assay (LFA) is an extensively used paper-based platform for the rapid and
on-site detection of different analytes. The method is user-friendly with no need for …

[HTML][HTML] Gold nanomaterials for oral cancer diagnosis and therapy: advances, challenges, and prospects

Q Zhang, D Hou, X Wen, M **n, Z Li, L Wu, JL Pathak - Materials Today Bio, 2022 - Elsevier
Early diagnosis and treatment of oral cancer are vital for patient survival. Since the oral
cavity accommodates the second largest and most diverse microbiome community after the …

Recent developments of aptamer-based lateral flow assays for point-of-care (POC) diagnostics

A Jaisankar, S Krishnan, L Rangasamy - Analytical Biochemistry, 2022 - Elsevier
In the field of lateral flow assay (LFA), the application of aptamer as a bioreceptor has been
implemented to overcome the limitations of antibodies, such as tedious in vivo processes …

Lateral flow assays for detection of disease biomarkers

E Gumus, H Bingol, E Zor - Journal of Pharmaceutical and Biomedical …, 2023 - Elsevier
Early diagnosis saves lives in many diseases. In this sense, monitoring of biomarkers is
crucial for the diagnosis of diseases. Lateral flow assays (LFAs) have attracted great …

[HTML][HTML] Gold nanoparticles and breast cancer: a bibliometric analysis of the current state of research and future directions

Y Bustanji, J Taneera, MH Semreen, E Abu-Gharbieh… - OpenNano, 2023 - Elsevier
Gold nanoparticles (GNPs) are widely searched for their usage in breast cancer research
because of their unique features. For example, these particles can deliver drugs to specific …

Point‐of‐Care Diagnoses and Assays Based on Lateral Flow Test

M Pohanka - International Journal of Analytical Chemistry, 2021 - Wiley Online Library
Analytical devices for point‐of‐care diagnoses are highly desired and would improve quality
of life when first diagnoses are made early and pathologies are recognized soon. Lateral …

A review: early detection of oral cancer biomarkers using microfluidic colorimetric point-of-care devices

A Balapure, S Goel, SK Dubey, A Javed… - Analytical …, 2024 - pubs.rsc.org
Oral squamous cell carcinoma (OSCC) is the most common type of head and neck cancers.
OSCC constitutes 90% of the head and neck malignancies. The delayed identification of oral …